Pinkie J. Eravuchira
Pinkie J. Eravuchira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pinkie J. Eravuchira has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Cristiano D'ANdrea
Istituto di Fisica Applicata
1 shared publication - Israel Gannot
Tel Aviv University, School of Biomedical Engineering, Faculty of Engineering, Tel Aviv, Israel
1 shared publication - Marella de Angelis
National Research Council of Italy, "Nello Carrara" Institute of Applied Physics (IFAC), via Madonna del Piano 10, 50019, Sesto Fiorentino (Florence), Italy
1 shared publication - Martina Banchelli
Institute of Applied Physics “Nello Carrara”, National Council for Research, CNR-IFAC, Via Madonna del Piano 10, I-50019 Sesto Fiorentino, Italy
1 shared publication - Paolo Matteini
Institute of Applied Physics “Nello Carrara”, National Research Council, 50019 Florence, Italy
1 shared publication
Latest Publications
- Open Access
- 2 July 2020
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 25 (07) , 077001-10
Hollow core photonic crystal fiber-assisted Raman spectroscopy as a tool for the detection of Alzheimer’s disease biomarkers
Alzheimer’s disease (AD) is a chronic, progressive, neurodegenerative disorder that affects several million people worldwide.1 – 4 AD is considered as one of the leading causes of dementia, and it is ranked as the fifth major cause of death. AD is pathologically characterized by the deposition of extracellular plaques composed of amyloid -peptide () and the aggregation of tau protein as intracellular neurofibrillary tangles in the brain.5 – 10 Specifically, the entorhinalcortex and hippocampus, which are brain areas dealing with cognitive abilities, are critically affected by the deposition of plaques and tangles in such a way that cognitive disabilities, including memory impairment, difficulties with reasoning and solving problems, and challenges with time and space, are among the prime distinctive symptoms of AD. The current antemortem AD diagnosis is based on monitoring the mental decline and on neuropsychological and laboratory tests. Nevertheless, the conclusive diagnosis of AD is still challenging requiring an autopsy substantiation of disease pathology.- 2 July 2020
- Published by SPIE-Intl Soc Optical Eng in Journal of Biomedical Optics
- Vol. 25 (07) , 077001-10
Open AccessHollow core photonic crystal fiber-assisted Raman spectroscopy as a tool for the detection of Alzheimer’s disease biomarkers
Alzheimer’s disease (AD) is a chronic, progressive, neurodegenerative disorder that affects several million people worldwide.1 – 4 AD is considered as one of the leading causes of dementia, and it is ranked as the fifth major cause of death. AD is pathologically characterized by the deposition of extracellular plaques composed of amyloid -peptide () and the aggregation of tau protein as intracellular neurofibrillary tangles in the brain.5 – 10 Specifically, the entorhinalcortex and hippocampus, which are brain areas dealing with cognitive abilities, are critically affected by the deposition of plaques and tangles in such a way that cognitive disabilities, including memory impairment, difficulties with reasoning and solving problems, and challenges with time and space, are among the prime distinctive symptoms of AD. The current antemortem AD diagnosis is based on monitoring the mental decline and on neuropsychological and laboratory tests. Nevertheless, the conclusive diagnosis of AD is still challenging requiring an autopsy substantiation of disease pathology.